ZA976777B - Anthelmintic formulations. - Google Patents

Anthelmintic formulations.

Info

Publication number
ZA976777B
ZA976777B ZA9706777A ZA976777A ZA976777B ZA 976777 B ZA976777 B ZA 976777B ZA 9706777 A ZA9706777 A ZA 9706777A ZA 976777 A ZA976777 A ZA 976777A ZA 976777 B ZA976777 B ZA 976777B
Authority
ZA
South Africa
Prior art keywords
anthelmintic formulations
anthelmintic
formulations
Prior art date
Application number
ZA9706777A
Other languages
English (en)
Inventor
Colin Manson Harvey
Original Assignee
Ashmont Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26651650&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA976777(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from NZ29909496A external-priority patent/NZ299094A/en
Application filed by Ashmont Holdings Ltd filed Critical Ashmont Holdings Ltd
Publication of ZA976777B publication Critical patent/ZA976777B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA9706777A 1996-07-30 1997-07-30 Anthelmintic formulations. ZA976777B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ29909496A NZ299094A (en) 1996-07-30 1996-07-30 Solutions containing praziquantel
NZ29938796 1996-09-13

Publications (1)

Publication Number Publication Date
ZA976777B true ZA976777B (en) 1998-02-11

Family

ID=26651650

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9706777A ZA976777B (en) 1996-07-30 1997-07-30 Anthelmintic formulations.

Country Status (6)

Country Link
US (1) US6165987A (xx)
EP (1) EP0959891A1 (xx)
AU (1) AU707949C (xx)
CA (1) CA2260143C (xx)
WO (1) WO1998006407A1 (xx)
ZA (1) ZA976777B (xx)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ335166A (en) * 1999-04-14 2001-11-30 Ashmont Holdings Ltd Anthelmintic composition containing triclabendazole in at least one solvent
WO2000078149A1 (en) * 1999-06-18 2000-12-28 Bayer Aktiengesellschaft Anthelmintic compositions
PT1197215E (pt) * 2000-10-10 2006-07-31 Wyeth Corp Composicoes antelminticas
GB0108485D0 (en) * 2001-04-04 2001-05-23 Pfizer Ltd Combination therapy
US20050009762A1 (en) * 2003-06-06 2005-01-13 Strobel Michael Albert Application of water and organic solvent soluble ivermectin for topical and oral use
US6627613B2 (en) 2001-07-23 2003-09-30 Michael A. Strobel Application of water and organic solvent soluble ivermectin for topical and oral use
US6893652B2 (en) 2001-08-27 2005-05-17 Wyeth Endoparasiticidal gel composition
CN1592577A (zh) * 2001-10-25 2005-03-09 三共生命科技株式会社 驱虫组合物
US20060205681A1 (en) * 2002-06-21 2006-09-14 Maryam Moaddeb Homogenous paste formulations
US7001889B2 (en) * 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
EP1578929A4 (en) 2002-06-21 2006-12-13 Divergence Inc SEQUENCES SIMILAR TO NEMATODENE-PHOSPHOETHANOLAMINE-N-METHYLTRANSFERASE
US7867749B2 (en) * 2002-06-21 2011-01-11 Divergence, Inc. Nematode phosphoethanolamine N-methyltransferase-like sequences
NZ520295A (en) * 2002-07-19 2005-04-29 Ashmont Holdings Ltd Anthelmintic formulations comprising levamisole and either an avermectin or milbemycin
NZ523128A (en) * 2002-12-12 2006-01-27 Ashmont Holdings Ltd Anthelmintic formulations containing avermectins and or milbemycins
HUE032009T2 (en) * 2003-04-04 2017-09-28 Merial Inc Veterinary preparations for topical veterinary use
US20050203067A1 (en) * 2003-05-12 2005-09-15 Hresko Michelle C. Pesticidal compositions and methods
TW200507751A (en) * 2003-05-12 2005-03-01 Divergence Inc Nematicidal compositions and methods
AU2004257228B8 (en) * 2003-07-09 2009-01-08 Life Technologies Corporation Method for assaying protein-protein interaction
DE602005021054D1 (de) * 2004-02-03 2010-06-17 Wyeth Llc Wurmmittel
US7854943B2 (en) * 2004-06-24 2010-12-21 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
US7618651B2 (en) * 2004-06-24 2009-11-17 Idexx Laboratories Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
US7858115B2 (en) * 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
NZ553656A (en) * 2004-09-09 2010-01-29 Warburton Technology Ltd Injectable composition for animals comprising trace elements and other components
US20080027011A1 (en) * 2005-12-20 2008-01-31 Hassan Nached Homogeneous paste and gel formulations
DE102007026550A1 (de) * 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
AU2008322995B2 (en) * 2007-11-15 2014-01-30 Novartis Tiergesundheit Ag Anthelmintic paste comprising praziquantel, a macrolide lactone, cyclodextrin and a thickener
US20100022469A1 (en) * 2008-06-24 2010-01-28 Majid Razzak Anthelminthic formulations
MX2009001235A (es) 2008-09-19 2010-04-29 Agrovet Market S A Composicion y uso de un gel oral endoparasiticida bioadhesivo de larga accion a base de doramectina.
PT2331068T (pt) * 2008-10-08 2017-03-13 Zoetis Services Llc Composições anti-helmínticas de benzimidazol
WO2010107791A2 (en) 2009-03-17 2010-09-23 Concert Pharmaceuticals, Inc. Pyrazinoisoquinoline compounds
EP3496714A4 (en) 2016-08-11 2020-04-22 Adamis Pharmaceuticals Corporation DRUG COMPOSITIONS.
WO2019113493A1 (en) 2017-12-08 2019-06-13 Adamis Pharmaceuticals Corporation Drug compositions
US11077134B1 (en) 2020-11-10 2021-08-03 Mountain Valley Md Inc Water dissolvable macrocyclic lactone cyclodextrin complexes
US11638714B2 (en) 2020-11-10 2023-05-02 Mountain Valley Md Inc Water dissolvable macrocyclic lactone cyclodextrin complexes

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141978A (en) * 1973-12-17 1979-02-27 Merck Patent Gesellschaft Mit Beschrankter Haftung 2-Acyl-4-oxo-pyrazino-isoquinoline derivatives and process for the preparation thereof
US4680419A (en) * 1985-07-22 1987-07-14 The Upjohn Company Spiroketals and process for preparing same
ES8800986A1 (es) * 1985-07-27 1987-12-01 Pfizer Un procedimiento para la produccion de un nuevo derivado de avermectina
NZ247278A (en) * 1991-02-12 1995-03-28 Ancare Distributors Veterinary anthelmintic drench comprising a suspension of praziquantel in a liquid carrier
US5340804A (en) * 1991-11-14 1994-08-23 Eli Lilly And Company 1,5-diphenyl-3-formazancarbonitril parasiticides
NZ260018A (en) * 1994-03-03 1995-10-26 Bomac Lab Ltd Benzimidazole compositions and anthelmintic compositions
AUPM969994A0 (en) * 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations
AU694016B2 (en) * 1995-05-10 1998-07-09 Virbac (Australia) Pty Limited Canine anthelmintic preparation
DE19520275A1 (de) * 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel

Also Published As

Publication number Publication date
EP0959891A1 (en) 1999-12-01
AU3560497A (en) 1998-03-06
US6165987A (en) 2000-12-26
WO1998006407A1 (en) 1998-02-19
EP0959891A4 (xx) 1999-12-22
AU707949B2 (en) 1999-07-22
AU707949C (en) 2006-01-19
CA2260143A1 (en) 1998-02-19
CA2260143C (en) 2004-07-13

Similar Documents

Publication Publication Date Title
ZA976777B (en) Anthelmintic formulations.
ZA993338B (en) Pharmaceutical formulations.
GB9715751D0 (en) Formulations
ZA971569B (en) Oral cyclosporin formulations.
ZA982253B (en) Therapeutic compositions.
ZA9811848B (en) Vaccine.
ZA984969B (en) Vaccine.
ZA988789B (en) Vaccine.
PL343021A1 (en) Formulations
ZA974735B (en) Pharmaceutical compositions.
ZA9710071B (en) Pharmaceutical composition.
ZA9710927B (en) Pharmaceutical composition.
ZA976815B (en) Vaccine composition.
ZA977104B (en) Pharmaceutical compositions.
HK1040488A1 (en) Pharmaceutical formulations.
ZA9810637B (en) Formulations comprising dissolved paroxetine.
ZA979725B (en) Benzoaxozole derivative.
ZA972602B (en) Pharmaceutical compositions.
ZA979483B (en) Anthelmintic formulation.
GB9815001D0 (en) Formulations
GB9815002D0 (en) Formulations
ZA988206B (en) Piperidinylmethyloxazolidinone derivative.
ZA977937B (en) Insecticidal composition.
IL127753A0 (en) Insect-repellent formulations
ZA984696B (en) Vaccine compositions V.